EPIGET

Description

Epirubicin is classified as an anthracycline antibiotic and is preferred for its significantly lower cardiotoxicity which makes it safer for elderly patients with breast cancer.

Indications:

  • As a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer
  •  
Generic Name Strength Standard Type Packing Pack Size
Epirubicin 20 10 mg BP USP Vial Vial
Epirubicin 80 50 mg BP USP Vial Vial